EOM Pharmaceuticals Holdings, Inc. (IMUC)

IMUC Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-5.13	-5.15	-1.94
Other Operating Activities	2.46	2.51	0.11
Change in Accounts Payable	-0.16	0.32	0.18
Change in Other Net Operating Assets	0.03	0.01	-
Operating Cash Flow	-2.79	-2.31	-1.65
Long-Term Debt Issued	-	2.5	-
Net Debt Issued (Repaid)	2.3	2.5	-
Issuance of Common Stock	-	-	2
Other Financing Activities	1.02	1.03	-
Financing Cash Flow	3.32	3.53	2
Net Cash Flow	0.54	1.22	0.35
Cash Interest Paid	0.08	0.01	-
Levered Free Cash Flow	-1.99	-1.5	-
Unlevered Free Cash Flow	-1.92	-1.48	-
Change in Net Working Capital	0.31	-0.15	-

Updated Dec 20, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.